Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis

References

• Casiano CA, Tan EM. Recent developments in the understanding of antinuclear autoantibodies. Int Arch Allergy Immunol 1996; 111: 308–313
   PubMedGoogle Scholar
• Fernandez-Gutierrez B, de Miguel S, Morado C, Hernandez-Garcia C, Banares A, Jover JA. Defective early T and T-dependent B cell activation in systemic lupus erythematosus. Lupus 1998; 7: 314–322
   Google Scholar
• Chan OT, Madaio MP, Shlomchik MJ. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999; 169: 107–121
   PubMed Web of Science ®Google Scholar
• Von Hoegen I, Nakayama E, Parnes JR. Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA. J Immunol 1990; 144: 4870–4877
   Google Scholar
• Nakayama E, von Hoegen I, Parnes JR. Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation. Proc Natl Acad Sci USA 1989; 86: 1352–1356
   PubMedGoogle Scholar
• Gordon J. B-cell signalling via the C-type lectins CD23 and CD72. Immunol Today 1994; 15: 411–417
   PubMedGoogle Scholar
• Tutt Landolfi M, Parnes JR, . CD72 workshop panel report. Leukocyte typing 4, T Kishimoto, et al, 1997; 162–164
   Google Scholar
• Gordon J, Katira A, Strain AJ, Gillis S. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40. Eur J Immunol 1991; 21: 1917–1922
   PubMedGoogle Scholar
• Subbarao B, Mosier DE. Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies. J Exp Med 1984; 159: 1796–1801
   PubMed Web of Science ®Google Scholar
• Yakura H, Kawabata I, Ashida T, Shen FW, Katagiri M. A role for Lyb-2 in B cell activation mediated by a B cell stimulatory factor. J Immunol 1986; 137: 1475–1481
   Google Scholar
• Adachi T, Flaswinkel H, Yakura H, Reth M, Tsubata T. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol 1998; 160: 4662–4665
   PubMed Web of Science ®Google Scholar
• Parenes JR, Pan C. CD72, a negative regulator of B cell responsiveness. Immunol Rev 2000; 176: 75–85
   Google Scholar
• Wakabayashi A, Adachi T, Wienands J, Tsubata T. A distinct signaling pathway used by the IgG-containing B cell antigen receptor. Science 2002; 298: 2392–2395
   PubMed Web of Science ®Google Scholar
• Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, Araki H, Hirata H, Iwahori K, Uchida J, Yasui T, Matsumoto M, Yoshida K, Yakura H, Pan C, Parnes JR, Kikutani H. Identification of CD72 as a lymphocyte receptor for the class 4 semaphorin CD100: A novel mechanism for regulating B-cell signaling. Immunity 2000; 13: 621–631
   PubMed Web of Science ®Google Scholar
• Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, Kikutani H. Functional soluble CD100/Sema4D released from activated lymphocytes: Possible role in normal and pathologic immune responses. Blood 2001; 97: 3498–3504
   PubMed Web of Science ®Google Scholar
• Ishida I, Kumanogoh A, Suzuki K, Akahani S, Noda K, Kikutani H. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: Implications for the regulation of immune and inflammatory responses. Int Immunol 2003; 15: 1027–1034
   PubMed Web of Science ®Google Scholar
• Kumanogoh A, Kikutani H. The CD100-CD72 interaction: A novel mechanism of immune regulation. Trends Immunol 2001; 22: 670–676
   PubMed Web of Science ®Google Scholar
• Delaire S, Elhabazi A, Bensussan A, Boumsell L. CD100 is a leukocyte semaphorin. Cell Mol Life Sci 1998; 54: 1265–1276
   PubMed Web of Science ®Google Scholar
• Kikutani H, Kumanogoh A. Semaphorin in interactions between T cells and antigen presenting cells. Nat Rev Immunol 2003; 3: 159–167
   PubMed Web of Science ®Google Scholar
• Qu WM, Miyazaki T, Terada M, Lu LM, Nishihara M, Yamada A, Mori S, Nakamura Y, Ogasawara H, Yazawa C, Nakatsuru S, Nose M. Genetic dissection of vasculitis in MRL/lpr lupus mice: A novel susceptibility locus involving the CD72c allele. Eur J Immunol 2000; 30: 2027–2037
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1734
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. The committee on prognosis studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640
   PubMed Web of Science ®Google Scholar
• Smith AJ, Gordon TP, Macardle PJ. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome. Tissue Antigen 2004; 63: 255–259
   PubMedGoogle Scholar
• Hitomi Y, Tsuchiya N, Kawasaki A, Ohashi J, Suzuki T, Kyogoku C, Fukazawa T, Bejrachandra S, Siriboonrit U, Chandanayingyong D, Suthipinittharm P, Tsao BP, Hashimoto H, Honda Z, Tokunaga K. CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B. Hum Mol Genet 2004; 13: 2907–2917
   PubMed Web of Science ®Google Scholar
• Lefkowith JB, Gilkeson GS. Nephritogenic auto-antibodies in lupus. Arthritis Rheum 1996; 39: 894–903
   PubMed Web of Science ®Google Scholar
• Forger F, Matthias T, Oppermann M, Becker H, Helmke K. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 2004; 13: 36–44
   PubMed Web of Science ®Google Scholar
• Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells. Semin Immunol 1994; 6: 295–301
   Google Scholar
• Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol 2003; 3: 822–829
   PubMed Web of Science ®Google Scholar
• Kato K, Santana-Sahagun E, Rassenti LZ, Weisman MH, Tamura N, Kobayashi S, Hashimoto H, Kipps TJ. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest 1999; 104: 947–955
   PubMed Web of Science ®Google Scholar